SCHEMBL4295916

SCHEMBL4295916

Cc1c(C(=O)O)ccc(-c2ccccc2)c1Nc1nc2ccc(F)cc2s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
LRRK2 Q5S007 1/20 0.51
KMT2A Q03164 5/20 0.51
HPGD P15428 4/20 0.51
HTT P42858 4/20 0.51
KDM4E B2RXH2 4/20 0.51
LMNA P02545 4/20 0.51
MEN1 O00255 4/20 0.51
ALDH1A1 P00352 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
USP2 O75604 1/20 0.51
TP53 P04637 1/20 0.51
CASP1 P29466 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284382 0.94 MAPT (0.49) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL4295922 0.78 MAPT (0.51) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL27706428 0.78 LRRK2 (0.57) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761569 0.75 DGAT1 (0.62) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761329 0.73 DGAT1 (0.61) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761458 0.72 DGAT1 (0.63) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761475 0.72 MAPT (0.60) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761459 0.71 MAPT (0.58) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL3787846 0.71 DYRK1A (0.76) MAPTSMN1; SMN2NPC1RAB9ALRRK2
SCHEMBL1761358 0.71 DGAT1 (0.57) MAPTSMN1; SMN2NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805156-A4 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORP (US) 2009-06-10 EP disclosed
EP-1805156-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2007-07-11 EP disclosed
WO-2006044775-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2006-04-27 WO disclosed